CLINICAL_TRIALS
trial_result
· 2021-07-14
Clinical Trial Update: Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. [Phase 2]
Summary
Phase 2 trial update of lurbinectedin monotherapy in patients with progressive malignant pleural mesothelioma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Swiss Cancer Institute | Conditions: Malignant Pleural Mesothelioma, Advanced | Phase 2 | Status: COMPLETED